Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adults | 1 |
| Brain | 1 |
| Cognitive Processes | 1 |
| Diseases | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Neurological Impairments | 1 |
| Outcomes of Treatment | 1 |
| Patients | 1 |
| Rewards | 1 |
Source
| Brain | 1 |
Author
| Barker, R. A. | 1 |
| Eckstein, D. | 1 |
| Fallon, S. | 1 |
| Ghosh, B. C. P. | 1 |
| Hughes, L. | 1 |
| Owen, A. M. | 1 |
| Rowe, J. B. | 1 |
| Williams-Gray, C. H. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
| United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Parkinson's Disease and Dopaminergic Therapy--Differential Effects on Movement, Reward and Cognition
Peer reviewed
Direct linkRowe, J. B.; Hughes, L.; Ghosh, B. C. P.; Eckstein, D.; Williams-Gray, C. H.; Fallon, S.; Barker, R. A.; Owen, A. M. – Brain, 2008
Cognitive deficits are very common in Parkinson's disease particularly for "executive functions" associated with frontal cortico-striatal networks. Previous work has identified deficits in tasks that require attentional control like task-switching, and reward-based tasks like gambling or reversal learning. However, there is a complex…
Descriptors: Diseases, Patients, Rewards, Drug Therapy
